$15.690
-0.207 (-1.32%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RLYB Prediction & Forecast by Similar Chart Analysis
Alphio's RLYB stock price prediction model matches the current Rallybio Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.54 (-0.98%). The 1-week path is $14.63 (-6.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Rallybio Corp Stock?
Rallybio Corp is currently not a strong buy due to its recent performance and risks associated with the merger. The stock is trading at $15.76, with an RSI of 37.96 indicating it is oversold. Additionally, the forward P/E ratio is currently at 0, suggesting uncertainty in future earnings. The stock has seen a significant year-to-date increase of 178.52%, but recent news about a $50 million termination fee raises concerns about its financial stability. Therefore, while there is potential for recovery, the risks outweigh the benefits at this moment.
RLYB stock price ended at $15.69 on Thursday, after losing -1.32%
Rallybio Corp (RLYB) last closed at $15.6899996, losing -1.32%. These facts feed the 1-day and 1-week RLYB price prediction above.
Forecast Drivers
Rallybio Corp (RLYB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches RLYB, ranked by similarity.
Seasonality analysis for RLYB
Historically the probability of a positive November return for RLYB is 11.36%. June offers the highest probability of a positive month at 35.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RLYB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.45 | $0.47 | $0.48 | -97.03% |
| Dec 2026 | $0.48 | $0.52 | $0.55 | -96.71% |
In 2026, Rallybio Corp (RLYB) is projected to range from $0.45 to $0.55.
Rallybio Corp 2026 monthly forecast
In Nov 2026, Rallybio Corp is projected to average $0.47, with a low of $0.45 and high of $0.48.
In Dec 2026, Rallybio Corp is projected to average $0.52, with a low of $0.48 and high of $0.55.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.